Well-differentiated Pancreatic Neuroendocrine Tumors: Prognostic Significance of Pathological Parameters Abstract #971

Introduction: Well-differentiated (WD) pancreatic neuroendocrine tumors (pNET) are uncommon neoplasms and one challenge lies in predicting tumor behavior and managing these patients.
Aim(s): To evaluate contemporary outcomes associated with the surgical management of WD pNET and to assess the prognostic and biological behavior differences between the 2 grades of WD pNET.
Materials and methods: Patients with pancreatic neuroendocrine neoplasms in the last 15 years were retrospectively analysed. Histopathological findings and actual status of patients with grade 1(G1) and 2(G2) WD pNET were collected.
Conference: 11th Annual ENETS Conference (2014)
Category: Pathology, grading, staging
Presenting Author: Luis Pérez-Casanova

To read results and conclusion, please login ...

Further abstracts you may be interested in

#2273 The Clinical Value of Circulating Transcript Analysis (NETest) during Follow-Up of Resected Well-Differentiated Pancreatic Neuroendocrine Tumors
Introduction: Follow-up after resection of pancreatic neuroendocrine tumors (pNET) is designed to detect recurrence early, as incidence is reported up to 48%.
Conference: 15th Annual ENETS conference (2018)
Category: Biomarkers
Presenting Author: M.D. Cansu Genc
#1422 Cystic Pancreatic Neuroendocrine Tumors: A Clinicopathologic Study and Long-term Follow-up after Surgical Resection in a Single Institution
Introduction: Cystic pancreatic endocrine tumors (CPETs) are rare lesions accounting for 2–17% of all endocrine pancreatic neoplasms. Their natural history and prognostic factors remain unclear
Conference: 13th Annual ENETS conference (2016)
Category: Surgical treatment
Presenting Author: dr Anna Malpaga
Keywords: pancreas, cystic
#2133 Clinicopathological Features of the High Grade Pancreatic Neuroendocrine Neoplasms
Introduction: The high grade pancreatic neuroendocrine neoplasms (PanNENs) include well-differentiated tumors (WD-NETs) with elevated proliferation and poorly differentiated carcinomas (PD-NECs).
Conference: 15th Annual ENETS conference (2018)
Category: Pathology - grading, staging
Presenting Author: Vera Delektorskaya
#938 Clinical Characteristics of 144 patients (pts) Included in a Multidisciplinary Group, with Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) G2 (WHO 2010). Grupo Argentum.
Introduction: Neuroendocrine tumors (NETs) G2 of the digestive tract are a heterogeneous group of tumors. Several treatment options including chemotherapy and target therapy are used, but there is a lack of prospective trials assessing the role of predictive factors in this population.
Conference: 11th Annual ENETS Conference (2014)
Category: Epidemiology/Natural history/Prognosis - Descriptive epidemiology
Presenting Author: MD Juan Manuel O'Connor
#1840 Genetic Features and Immunoprofile of Sporadic Well-Differentiated Neuroendocrine Tumors of Gastric
Introduction: Well-differentiated Type III gastric neuroendocrine tumors (gNET III) are histologically distinct subset that have a unique pathogenesis and clinical course.
Conference: 14th Annual ENETS conference (2017)
Category: Basic Science - Genetics, epigenetics, miRNAs, Omics
Presenting Author: Prof. Yuan Ji
Authors: Xie Y, Xu Y, Zeng H, Wang H, ...
Keywords: genetic, wdnet.